Pertzye (amylases 15,125 UNT / endopeptidases 14,375 UNT / lipase 4000 UNT) Delayed Release Oral Capsule
- RxCUI
- 1543006
- RxNorm name
- Pertzye (amylases 15,125 UNT / endopeptidases 14,375 UNT / lipase 4000 UNT) Delayed Release Oral Capsule
- Display name
- Pertzye (amylases 15,125 UNT / endopeptidases 14,375 UNT / lipase 4000 UNT) Delayed Release Oral Capsule
- Full name
- Pertzye (amylases 15,125 UNT / endopeptidases 14,375 UNT / lipase 4000 UNT) Delayed Release Oral Capsule
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:56
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 022175 | Pertzye | pancrelipase | 351(a) | Rx | 2026-07-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PERTZYE | PANCRELIPASE | Digestive Care, Inc. | 481eec00-9abf-11dd-b71c-0002a5d5c51b | 2024-03-11 | Warnings, Adverse reactions | 1543006 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 481eec00-9abf-11dd-b71c-0002a5d5c51b | Pertzye 4000 UNT / 15,125 UNT / 14,375 UNT Delayed Release Oral Capsule [PSN] · amylase 15125 UNT / lipase 4000 UNT / protease 14375 UNT Delayed Release Oral Capsule [Pertzye] [SBD] · Pertzye (amylase 15,125 UNT / lipase 4000 UNT / protease 14,375 UNT) Delayed Release Oral Capsule [SY] · Pertzye (amylases 15,125 UNT / endopeptidases 14,375 UNT / lipase 4000 UNT) Delayed Release Oral Capsule [SY] | 4 | 22 | These highlights do not include all the information needed to use PERTZYE safely and effectively. See full prescribing information for PERTZYE. PERTZYE (pancrelipase) delayed-release capsules, for oral use Initial U.S. Approval: 2012 | 20240311 |